What is the efficacy of naloxone (Narcan) in lisinopril overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Naloxone Has No Efficacy in Lisinopril Overdose

Naloxone (Narcan) is NOT indicated for lisinopril overdose and should not be used. Naloxone is an opioid antagonist that works exclusively by blocking opioid receptors—it has no mechanism of action relevant to ACE inhibitor toxicity 1.

Why This Question Arises

There is one case report from 2023 describing apparent improvement in hypotension after naloxone administration in a lisinopril overdose 2. However, this represents anecdotal evidence from a single patient and does not establish causation. The hypotension may have resolved spontaneously or due to other interventions.

Correct Management of Lisinopril Overdose

According to the FDA drug label, lisinopril overdose management consists of 3:

  • Hypotension is the primary manifestation of overdose
  • Intravenous normal saline infusion is the standard treatment
  • Hemodialysis can remove lisinopril if needed in severe cases

Treatment Algorithm:

  1. IV fluid resuscitation with normal saline for hypotension
  2. Supportive care including airway management if needed
  3. Hemodialysis for refractory cases or massive ingestions
  4. Monitor and treat complications (hyperkalemia, acute kidney injury)

Why Naloxone Should Not Be Used

The FDA-approved indications for naloxone are explicit 1:

  • Emergency treatment of known or suspected opioid overdose
  • Manifested by respiratory and/or CNS depression from opioids

Naloxone works by competitively antagonizing μ-opioid receptors. Lisinopril is an ACE inhibitor that works through the renin-angiotensin-aldosterone system—there is no pharmacologic overlap between these mechanisms.

Common Pitfall to Avoid

Do not be misled by isolated case reports suggesting benefit from off-label interventions. The single case report 2 does not provide sufficient evidence to change standard practice, especially when:

  • The mechanism of action makes no pharmacologic sense
  • Standard effective treatments exist
  • Using naloxone would delay appropriate therapy

Focus on proven interventions: IV fluids and supportive care for lisinopril overdose, reserving naloxone exclusively for opioid toxicity.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.